Patents matching “formulation”

US 10548890

Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same

Platform Brightworks Two, Ltd. · Granted Feb 4, 2020 · Expires Jan 30, 2040

US 10548860

HIF-1 modulator paint formulation and uses thereof

United States Government as represented by the Department of Veterans Affairs · Granted Feb 4, 2020 · Expires Jan 30, 2040

US 10543221

Beta-lactamase inhibitors, formulations, and uses thereof

The Regents of the University of California · Granted Jan 28, 2020 · Expires Jan 23, 2040

US 10532050

Formulations of oxabicycloheptanes and oxabicycloheptenes

Lixte Biotechnology, Inc. · Granted Jan 14, 2020 · Expires Jan 9, 2040

US 10531680

Creatine ester pronutrient compounds and formulations

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jan 14, 2020 · Expires Jan 9, 2040

US 10525052

Abuse-deterrent drug formulations

Collegium Pharmaceutical, Inc. · Granted Jan 7, 2020 · Expires Jan 2, 2040

CA 3103212

FORMULATIONS COMPRENANT DES INHIBITEURS DE LA DOPAMINE-S-HYDROXYLASE ET LEURS PROCEDES DE PREPARATION

BIAL PORTELA & CA SA [PT] · Granted Jan 2, 2020 · Expires Dec 28, 2039

US 10519175

Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

COMPASS Pathways Limited · Granted Dec 31, 2019 · Expires Dec 26, 2039

US 10512609

Formulations of (R)-2-amino-3-phenylpropyl carbamate

Jazz Pharmaceuticals Ireland Limited · Granted Dec 24, 2019 · Expires Dec 19, 2039

US 10512675

Adeno-associated virus factor VIII vectors, associated viral particles and therapeutic formulations comprising the same

BIOMARIN PHARMACEUTICAL INC. · Granted Dec 24, 2019 · Expires Dec 19, 2039

US 10512682

Norovirus vaccine formulations

Takeda Vaccines, Inc. · Granted Dec 24, 2019 · Expires Dec 19, 2039

US 10500284

Pharmaceutical formulation

Semnur Pharmaceuticals, Inc. · Granted Dec 10, 2019 · Expires Dec 5, 2039

US 10499682

Micronutrient formulation in electronic cigarettes

New Age Beverage Corporation · Granted Dec 10, 2019 · Expires Dec 5, 2039

US 10500208

Emulsion formulations of aprepitant

Heron Therapeutics, Inc. · Granted Dec 10, 2019 · Expires Dec 5, 2039

US 10500281

Injectable long-acting local anesthetic semi-solid formulations and its compositions

MIRA PHARMA CORPORATION · Granted Dec 10, 2019 · Expires Dec 5, 2039

US 10494327

Controlled release pharmaceutical formulations

United Therapeutics Corporation · Granted Dec 3, 2019 · Expires Nov 28, 2039

US 10493038

Formulation of acoustically activatable particles having low vaporization energy and methods for using same

Arizona Board of Regents on Behalf of the University of Arizona · Granted Dec 3, 2019 · Expires Nov 28, 2039

US 10493151

Etanercept formulations stabilized with sodium chloride

Coherus BioSciences, Inc. · Granted Dec 3, 2019 · Expires Nov 28, 2039

US 10493103

Peroxide formulations and methods and applicators for using the same

Aclaris Therapeutics, Inc. · Granted Dec 3, 2019 · Expires Nov 28, 2039

US 10493149

Stable anti-OSMR antibody formulation

Kiniksa Pharmaceuticals, GmbH · Granted Dec 3, 2019 · Expires Nov 28, 2039

US 10493065

Formulations and methods of manufacturing formulations for use in colonic evacuation

RedHill Biopharma Ltd. · Granted Dec 3, 2019 · Expires Nov 28, 2039

US 10485850

Methods for producing stable therapeutic formulations in aprotic polar solvents

XERIS PHARMACEUTICALS, INC. · Granted Nov 26, 2019 · Expires Nov 21, 2039

US 10485869

Etanercept formulations stabilized with meglumine

Coherus BioSciences, Inc. · Granted Nov 26, 2019 · Expires Nov 21, 2039

US 10479868

Polymeric stabilizing formulations

Nano Precision Medical, Inc. · Granted Nov 19, 2019 · Expires Nov 14, 2039